Global Vaccine Vial Market, by Product Type (Molded Glass Vial, Tubular Glass Vial), Material (Glass, Polymer), Application (Preventive Vaccine, Therapeutic Vaccine), Capacity (2ml, 3ml, 5ml, 10 ml,20 ml) Region – Growth, COVID-19 Impact, Trends, and Forecasting till 2028

The global vaccine vial market size is estimated at 900.13 USD billion by 2028 and is anticipated to grow at a CAGR of 10.5 % during the projected time frame (2021-2028).

Market Overview

The global vaccine vial market size is estimated at 900.13 USD billion by 2028 and is anticipated to grow at a CAGR of 10.5 % during the projected time frame (2021-2028). Vaccine vial is a small bottle used to store vaccines, capsules, liquids, or other medications. They are made of glass or plastic and stored under specific temperatures. Vials are also known as flacons or phials. The major factor driving the vaccine vial market is the coronavirus pandemic and increasing number of COVID-19 cases. Increasing awareness about the pandemic and growing immunization are expected to contribute to market growth. Due to rapid increasing in COVID-19 cases, the vaccine vial market is undergoing shortage in supply. The shortage in vaccine vial supply can hinder the market growth during the forecast period. Healthcare infrastructures in developing countries are not fully developed, which causing serious challenges to market due to unaffordability of advanced healthcare technology. Government and companies are making hefty investments worth millions of dollars to support the manufacturing of vaccine vials to meet the increasing demand, which is expected to create market growth opportunities during the forecast period. The COVID-19 pandemic has affected the supply chain and production of various industries including the vaccine vial market. Increases COVID-19 patients and shortage of vaccine vials has severely impacted the market. However, government initiatives to enhance the vial production is expected to have a positive impact on market growth. Vial manufacturing companies have increased their production capacities by 10% to meet the increasing demand. All these factors are expected to augment the market growth during the forecast period.

TABLE 1:GLOBAL MARKETSCOPE

Parameters Covered
Report Title Global Vaccine Vial Market Report
Market Size and Forecasting 2018-2028
Base Year 2020
Estimated Year 2021
Forecast Period 2021-2028
Market Sizing Units Value in USD Billion
Market Segmentation Covered Product Type, Material, Application, Capacity, and Region
Regions North America, Europe, Asia Pacific, Middle East and Africa, and South America
Major Key Players Schott AG, Thermo Fisher Scientific Inc., DWK Life Sciences, Pacific Vial Manufacturing, Nipro Corporation, Pacific Vial Manufacturing Inc., Shandong Pharmaceutical Packaging Company.
Number of Pages of Report 180
Customization Available Yes, Customization Is Available As Per The Requirements

Market Segmentation of Vaccine Vial Market

Product Type of Vaccine Vial Market By product type, the market is classified into molded glass vial and tubular glass vial. The tubular glass vial segment is expected to dominate the market during the forecast period. The segment growth can be attributed to light weightedness, superior fill-level consistency, clarity facilitated vision inspection, and customized packaging. Tubular glass vials are used to store vaccines, injection powder, penicillin, and lyophilized powder. They are used as automatic inspection system to control appearance and tolerance. Material Analysis of Vaccine Vial Market By material, the market is classified into glass and polymer. The glass segment is expected to hold highest market share. The segment growth can be because glass has enhanced visibility, impermeability, and thermal stability. It also prevents the product from contamination due to oxygen, moisture, and chemical as it has barrier and chemical resistance properties. It retains its shape even at temperatures as high as 500°C and even at 0°C. These factors are expected to contribute to glass vial segment during the forecast period. Application of Vaccine Vial Market By application, the market is classified into preventive vaccine and therapeutic vaccine. The therapeutic vaccine segment is expected to observe fastest growth during the forecast period. Therapeutic vaccines are used to treat viral infections and cancers. The coronavirus pandemic and increasing prevalence of cancer are expected to drive segment growth. Application of Vaccine Vial Market Capacity of Vaccine Vial Market By capacity, the market is classified into 2 ml, 3 ml, 5 ml, 10 ml, and 20 ml. The 10 ml segment is expected to dominate the market during the forecast period. The segment growth can be attribute to increasing use of single dose vaccines in treating various disorders. Regional Analysis of Vaccine Vial Market Regional Analysis of Vaccine Vial Market By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and South America. Asia Pacific is expected to be the fastest growing market during the forecast period. The regional growth can be due to increasing population and increasing prevalence of diseases. Increasing demand for vaccines and presence of developed pharmaceutical and healthcare companies are expected to contribute to regional market growth. Key Companies listed The major companies listed in the vaccine vial market Schott AG, Thermo Fisher Scientific Inc., DWK Life Sciences, Pacific Vial Manufacturing, Nipro Corporation, Pacific Vial Manufacturing Inc., and Shandong Pharmaceutical Packaging Company. These companies are spread over North America, Europe, South America, and Asia Pacific markets, which empowers it to take into account clients over the globe. The company’s leading position in the Vaccine Vial marketis endorsed by its wide product portfolio. Key Development
  • In July 2021,ZandCell signed various contracts with number of governments in South America, Asia, and Africa to manufacture the Russian vaccines vials for distributing worldwide. The aim was to manufacture and sale of 160 million COVID-19 doses in less developed countries.
  • In April 2021,The US Food and Drug Administration (FDA) approved new vials from Moderna, that can contain up till 15 doses each as compared to original vials designed to hold 10 doses. Providers can extract up till 11 doses from original 10 dose vials.

Market Segmentation

By Product Type
  • Molded Glass Vial
  • Tubular Glass Vial
By Material
  • Glass
  • Polymer
By Application
  • Preventive Vaccine
  • Therapeutic Vaccine
By Capacity
  • 2 ml
  • 3 ml
  • 5 ml
  • 10 ml
  • 20 ml
By Region
  • North America Vaccine Vial Market
  • Europe Vaccine Vial Market
  • Asia Pacific Vaccine Vial Market
  • Middle East & Africa Vaccine Vial Market
  • South America Vaccine Vial Market

Table of Contents
Chapter 1. Executive Summary
Chapter 2. Market Introduction
Chapter 3. Global Vaccine Vial Market – Analysis and Revenue Forecast 2021-2028 – Key Industry Dynamics
3.1. Key Market Drivers
3.2. Key Market Restraints
3.3. Market Opportunities
3.4. Future Trends
3.5. Impact Analysis of Drivers and Restraints
3.6. COVID-19 Impact Analysis
3.7. Major Developments in the Market
Chapter 4. Global Vaccine Vial Market – Analysis and Revenue Forecast 2021-2028
Chapter 5. Global Vaccine Vial Market – Analysis and Revenue Forecast 2021-2028 – By Type
5.1. Type 1
5.2. Type 2
5.3. Type 3
Chapter 6. Global Vaccine Vial Market – Analysis and Revenue Forecast 2021-2028 – By End User
6.1. End User 1
6.2. End User 2
6.3. End User 3
Chapter 7. Global Vaccine Vial Market – Analysis and Revenue Forecast 2021-2028 – By Region
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. Middle East & Africa
7.5. South America
Chapter 8. North America Market – Analysis and Revenue Forecast 2021-2028
8.1. Vaccine Vial Market Market – By Type
8.1.1. Type 1
8.1.2. Type 2
8.1.3. Type 3
8.2. North America Vaccine Vial Market Market – By End User
8.2.1. End User 1
8.2.2. End User 2
8.2.3. End User 3
8.3. North America Vaccine Vial Market Market – By Country
8.3.1. U.S.
8.3.2. Canada
Chapter 9. Europe Vaccine Vial Market Market – Analysis and Revenue Forecast 2021-2028
9.1. Europe Vaccine Vial Market Market – By Type
9.1.1. Type 1
9.1.2. Type 2
9.1.3. Type 3
9.2. Europe Vaccine Vial Market –By End User
9.2.1. End USER 1
9.2.2. END USER 2
9.2.3. END USER 3
9.3. EuropeVaccine Vial Market Market – By Country
9.3.1. Germany
9.3.2. France
9.3.3. UK
9.3.4. Spain
9.3.5. Italy
9.3.6. Rest of Europe
Chapter 10. Asia Pacific Vaccine Vial Market – Analysis and Revenue Forecast 2021-2028
10.1. Asia Pacific Vaccine Vial Market Market – By Type
10.1.1. Type 1
10.1.2. Type 2
10.1.3. Type 3
10.2. Asia Pacific DNA Based Cancer Detection Market – By End User
10.2.1. End USER 1
10.2.2. END USER 2
10.2.3. END USER 3
10.3. Asia Pacific Vaccine Vial Market Market – By Country
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Rest of Asia Pacific
Chapter 11. South America Vaccine Vial Market Market – Analysis and Revenue Forecast 2021-2028
11.1. South AmericaVaccine Vial Market Market – By Type
11.1.1. Type 1
11.1.2. Type 2
11.1.3. Type 3
11.2. South America Vaccine Vial Market Market – By End User
11.2.1. End User 1
11.2.2. End User 2
11.2.3. End User 3
11.3. South America Vaccine Vial Market Market – By Country
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of South America
Chapter 12. Middle East & Africa Vaccine Vial Market Market – Analysis and Revenue Forecast 2021-2028
12.1. Middle East & Africa Vaccine Vial Market Market – By Type
12.1.1. Type 1
12.1.2. Type 2
12.1.3. Type 3
12.2. Middle East & Africa Vaccine Vial Market Market – By End User
12.2.1. End User 1
12.2.2. End User 2
12.2.3. End User 3
12.3. Middle East & Africa Vaccine Vial Market Market – By Country
12.3.1. UAE
12.3.2. Saudi Arabia
12.3.3. Turkey
12.3.4. Rest of Middle East & Africa
Chapter 13. Competitive Analysis
13.1.1. Competition Dashboard
13.1.2. Company Profiles
13.1.2.1. Company 1
13.1.2.2. Company 2
13.1.2.3. Company 3
13.1.2.4. Company 4
13.1.2.5. Company 5
13.1.2.6. Company 6
13.1.2.7. Company 7
13.1.2.8. Company 8
13.1.2.9. Company 9
13.1.2.10. Company 10

 

  • Thermo Fisher Scientific Inc.
  • DWK Life Sciences
  • Pacific Vial Manufacturing
  • Nipro Corporation
  • Pacific Vial Manufacturing Inc.
  • Shandong Pharmaceutical Packaging Company

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS